Dear Valued Customer,
We are issuing this notification to inform you that the products listed in Table 1 are being discontinued from our portfolio.
Table 1: Impacted Products
Material #
|
Description
|
Date of Discontinuation
|
0710-0411
|
Seraseq Breast CNV Mix, + 3 copies
|
15 August 2025
|
0710-0412
|
Seraseq Breast CNV Mix, + 6 copies
|
25 July 2025
|
0710-0413
|
Seraseq Breast CNV Mix, + 12 copies
|
15 August 2025
|
0710-0414
|
Seraseq Lung & Brain CNV Mix, + 3 copies
|
03 June 2025
|
0710-0415
|
Seraseq Lung & Brain CNV Mix, + 6 copies
|
15 August 2025
|
0710-0416
|
Seraseq Lung & Brain CNV Mix, + 12 copies
|
15 August 2025
|
As a part of our ongoing efforts to streamline and enhance our offerings, we are discontinuing these products following the consolidation of two product lines with the same copy number constructs into a single, more comprehensive product. The corresponding new products also include added content, offering superior value. Please refer to Table 2 for the corresponding replacement products.
Table 2: Replacement Products Available for Purchase
We will continue to fulfill orders of the legacy products until the official discontinuation date or until our inventory is depleted, whichever occurs first. Furthermore, we remain committed to supporting custom product requests as needed.
Thank you for your attention to this change. Please contact Customer Service at CDx-info@LGCgroup.com or your LGC sales representative if you have any questions.

Sincerely,
Praveena Kamineni
LGC Clinical Diagnostics | Associate Product Manager, Oncology
